Selected research
Market Analysis & Forecast
Global Nitroglycerin for Angina Market Analysis and Forecast 2026-2032
Market perspective
The global Nitroglycerin for Angina market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nitroglycerin for Angina is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Nitroglycerin for Angina is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Nitroglycerin for Angina is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Nitroglycerin for Angina is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Nitroglycerin for Angina include Sandoz, Mylan, Pfizer, Us Pharma, Sigmapharm Laboratories, Hercon Pharmaceuticals, Glenmark, Espero Pharmaceuticals and Dr. Reddy's Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Nitroglycerin for Angina, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Nitroglycerin for Angina, also provides the sales of main regions and countries. Of the upcoming market potential for Nitroglycerin for Angina, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nitroglycerin for Angina sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nitroglycerin for Angina market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nitroglycerin for Angina sales, projected growth trends, production technology, application and end-user industry.
Nitroglycerin for Angina Segment by Company
Sandoz
Mylan
Pfizer
Us Pharma
Sigmapharm Laboratories
Hercon Pharmaceuticals
Glenmark
Espero Pharmaceuticals
Dr. Reddy's Laboratories
Nitroglycerin for Angina Segment by Type
Transdermal
Tablet
Powder
Nitroglycerin for Angina Segment by Application
Relief
Prophylaxis
Nitroglycerin for Angina Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitroglycerin for Angina market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitroglycerin for Angina and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitroglycerin for Angina.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nitroglycerin for Angina in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nitroglycerin for Angina sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transdermal
- Tablet
- Powder
Applications
- Relief
- Prophylaxis
Companies covered
- Sandoz
- Mylan
- Pfizer
- Us Pharma
- Sigmapharm Laboratories
- Hercon Pharmaceuticals
- Glenmark
- Espero Pharmaceuticals
- Dr. Reddy's Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Nitroglycerin for Angina Market by Type
- 1.2.1 Global Nitroglycerin for Angina Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Transdermal
- 1.2.3 Tablet
- 1.2.4 Powder
- 1.3 Nitroglycerin for Angina Market by Application
- 1.3.1 Global Nitroglycerin for Angina Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Relief
- 1.3.3 Prophylaxis
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Nitroglycerin for Angina Market Dynamics
- 2.1 Nitroglycerin for Angina Industry Trends
- 2.2 Nitroglycerin for Angina Industry Drivers
- 2.3 Nitroglycerin for Angina Industry Opportunities and Challenges
- 2.4 Nitroglycerin for Angina Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Nitroglycerin for Angina Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Nitroglycerin for Angina Revenue by Region
- 3.2.1 Global Nitroglycerin for Angina Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Nitroglycerin for Angina Revenue by Region (2021-2026)
- 3.2.3 Global Nitroglycerin for Angina Revenue by Region (2027-2032)
- 3.2.4 Global Nitroglycerin for Angina Revenue Market Share by Region (2021-2032)
- 3.3 Global Nitroglycerin for Angina Sales Estimates and Forecasts 2021-2032
- 3.4 Global Nitroglycerin for Angina Sales by Region
- 3.4.1 Global Nitroglycerin for Angina Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Nitroglycerin for Angina Sales by Region (2021-2026)
- 3.4.3 Global Nitroglycerin for Angina Sales by Region (2027-2032)
- 3.4.4 Global Nitroglycerin for Angina Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Nitroglycerin for Angina Revenue by Manufacturers
- 4.1.1 Global Nitroglycerin for Angina Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Nitroglycerin for Angina Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Nitroglycerin for Angina Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Nitroglycerin for Angina Sales by Manufacturers
- 4.2.1 Global Nitroglycerin for Angina Sales by Manufacturers (2021-2026)
- 4.2.2 Global Nitroglycerin for Angina Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Nitroglycerin for Angina Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Nitroglycerin for Angina Sales Price by Manufacturers (2021-2026)
- 4.4 Global Nitroglycerin for Angina Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Nitroglycerin for Angina Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Nitroglycerin for Angina Manufacturers, Product Type & Application
- 4.7 Global Nitroglycerin for Angina Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Nitroglycerin for Angina Market CR5 and HHI
- 4.8.2 2025 Nitroglycerin for Angina Tier 1, Tier 2, and Tier 3
5 Nitroglycerin for Angina Market by Type
- 5.1 Global Nitroglycerin for Angina Revenue by Type
- 5.1.1 Global Nitroglycerin for Angina Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Nitroglycerin for Angina Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Nitroglycerin for Angina Revenue Market Share by Type (2021-2032)
- 5.2 Global Nitroglycerin for Angina Sales by Type
- 5.2.1 Global Nitroglycerin for Angina Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Nitroglycerin for Angina Sales by Type (2021-2032) & (W Units)
- 5.2.3 Global Nitroglycerin for Angina Sales Market Share by Type (2021-2032)
- 5.3 Global Nitroglycerin for Angina Price by Type
6 Nitroglycerin for Angina Market by Application
- 6.1 Global Nitroglycerin for Angina Revenue by Application
- 6.1.1 Global Nitroglycerin for Angina Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Nitroglycerin for Angina Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Nitroglycerin for Angina Revenue Market Share by Application (2021-2032)
- 6.2 Global Nitroglycerin for Angina Sales by Application
- 6.2.1 Global Nitroglycerin for Angina Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Nitroglycerin for Angina Sales by Application (2021-2032) & (W Units)
- 6.2.3 Global Nitroglycerin for Angina Sales Market Share by Application (2021-2032)
- 6.3 Global Nitroglycerin for Angina Price by Application
7 Company Profiles
- 7.1 Sandoz
- 7.1.1 Sandoz Company Information
- 7.1.2 Sandoz Business Overview
- 7.1.3 Sandoz Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sandoz Nitroglycerin for Angina Product Portfolio
- 7.1.5 Sandoz Recent Developments
- 7.2 Mylan
- 7.2.1 Mylan Company Information
- 7.2.2 Mylan Business Overview
- 7.2.3 Mylan Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Mylan Nitroglycerin for Angina Product Portfolio
- 7.2.5 Mylan Recent Developments
- 7.3 Pfizer
- 7.3.1 Pfizer Company Information
- 7.3.2 Pfizer Business Overview
- 7.3.3 Pfizer Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer Nitroglycerin for Angina Product Portfolio
- 7.3.5 Pfizer Recent Developments
- 7.4 Us Pharma
- 7.4.1 Us Pharma Company Information
- 7.4.2 Us Pharma Business Overview
- 7.4.3 Us Pharma Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Us Pharma Nitroglycerin for Angina Product Portfolio
- 7.4.5 Us Pharma Recent Developments
- 7.5 Sigmapharm Laboratories
- 7.5.1 Sigmapharm Laboratories Company Information
- 7.5.2 Sigmapharm Laboratories Business Overview
- 7.5.3 Sigmapharm Laboratories Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sigmapharm Laboratories Nitroglycerin for Angina Product Portfolio
- 7.5.5 Sigmapharm Laboratories Recent Developments
- 7.6 Hercon Pharmaceuticals
- 7.6.1 Hercon Pharmaceuticals Company Information
- 7.6.2 Hercon Pharmaceuticals Business Overview
- 7.6.3 Hercon Pharmaceuticals Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Hercon Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 7.6.5 Hercon Pharmaceuticals Recent Developments
- 7.7 Glenmark
- 7.7.1 Glenmark Company Information
- 7.7.2 Glenmark Business Overview
- 7.7.3 Glenmark Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Glenmark Nitroglycerin for Angina Product Portfolio
- 7.7.5 Glenmark Recent Developments
- 7.8 Espero Pharmaceuticals
- 7.8.1 Espero Pharmaceuticals Company Information
- 7.8.2 Espero Pharmaceuticals Business Overview
- 7.8.3 Espero Pharmaceuticals Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Espero Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 7.8.5 Espero Pharmaceuticals Recent Developments
- 7.9 Dr. Reddy's Laboratories
- 7.9.1 Dr. Reddy's Laboratories Company Information
- 7.9.2 Dr. Reddy's Laboratories Business Overview
- 7.9.3 Dr. Reddy's Laboratories Nitroglycerin for Angina Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Dr. Reddy's Laboratories Nitroglycerin for Angina Product Portfolio
- 7.9.5 Dr. Reddy's Laboratories Recent Developments
8 North America
- 8.1 North America Nitroglycerin for Angina Market Size by Type
- 8.1.1 North America Nitroglycerin for Angina Revenue by Type (2021-2032)
- 8.1.2 North America Nitroglycerin for Angina Sales by Type (2021-2032)
- 8.1.3 North America Nitroglycerin for Angina Price by Type (2021-2032)
- 8.2 North America Nitroglycerin for Angina Market Size by Application
- 8.2.1 North America Nitroglycerin for Angina Revenue by Application (2021-2032)
- 8.2.2 North America Nitroglycerin for Angina Sales by Application (2021-2032)
- 8.2.3 North America Nitroglycerin for Angina Price by Application (2021-2032)
- 8.3 North America Nitroglycerin for Angina Market Size by Country
- 8.3.1 North America Nitroglycerin for Angina Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Nitroglycerin for Angina Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Nitroglycerin for Angina Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Nitroglycerin for Angina Market Size by Type
- 9.1.1 Europe Nitroglycerin for Angina Revenue by Type (2021-2032)
- 9.1.2 Europe Nitroglycerin for Angina Sales by Type (2021-2032)
- 9.1.3 Europe Nitroglycerin for Angina Price by Type (2021-2032)
- 9.2 Europe Nitroglycerin for Angina Market Size by Application
- 9.2.1 Europe Nitroglycerin for Angina Revenue by Application (2021-2032)
- 9.2.2 Europe Nitroglycerin for Angina Sales by Application (2021-2032)
- 9.2.3 Europe Nitroglycerin for Angina Price by Application (2021-2032)
- 9.3 Europe Nitroglycerin for Angina Market Size by Country
- 9.3.1 Europe Nitroglycerin for Angina Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Nitroglycerin for Angina Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Nitroglycerin for Angina Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Nitroglycerin for Angina Market Size by Type
- 10.1.1 China Nitroglycerin for Angina Revenue by Type (2021-2032)
- 10.1.2 China Nitroglycerin for Angina Sales by Type (2021-2032)
- 10.1.3 China Nitroglycerin for Angina Price by Type (2021-2032)
- 10.2 China Nitroglycerin for Angina Market Size by Application
- 10.2.1 China Nitroglycerin for Angina Revenue by Application (2021-2032)
- 10.2.2 China Nitroglycerin for Angina Sales by Application (2021-2032)
- 10.2.3 China Nitroglycerin for Angina Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Nitroglycerin for Angina Market Size by Type
- 11.1.1 Asia Nitroglycerin for Angina Revenue by Type (2021-2032)
- 11.1.2 Asia Nitroglycerin for Angina Sales by Type (2021-2032)
- 11.1.3 Asia Nitroglycerin for Angina Price by Type (2021-2032)
- 11.2 Asia Nitroglycerin for Angina Market Size by Application
- 11.2.1 Asia Nitroglycerin for Angina Revenue by Application (2021-2032)
- 11.2.2 Asia Nitroglycerin for Angina Sales by Application (2021-2032)
- 11.2.3 Asia Nitroglycerin for Angina Price by Application (2021-2032)
- 11.3 Asia Nitroglycerin for Angina Market Size by Country
- 11.3.1 Asia Nitroglycerin for Angina Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Nitroglycerin for Angina Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Nitroglycerin for Angina Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Nitroglycerin for Angina Market Size by Type
- 12.1.1 SAMEA Nitroglycerin for Angina Revenue by Type (2021-2032)
- 12.1.2 SAMEA Nitroglycerin for Angina Sales by Type (2021-2032)
- 12.1.3 SAMEA Nitroglycerin for Angina Price by Type (2021-2032)
- 12.2 SAMEA Nitroglycerin for Angina Market Size by Application
- 12.2.1 SAMEA Nitroglycerin for Angina Revenue by Application (2021-2032)
- 12.2.2 SAMEA Nitroglycerin for Angina Sales by Application (2021-2032)
- 12.2.3 SAMEA Nitroglycerin for Angina Price by Application (2021-2032)
- 12.3 SAMEA Nitroglycerin for Angina Market Size by Country
- 12.3.1 SAMEA Nitroglycerin for Angina Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Nitroglycerin for Angina Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Nitroglycerin for Angina Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Nitroglycerin for Angina Value Chain Analysis
- 13.1.1 Nitroglycerin for Angina Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Nitroglycerin for Angina Production Mode & Process
- 13.2 Nitroglycerin for Angina Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Nitroglycerin for Angina Distributors
- 13.2.3 Nitroglycerin for Angina Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst